James Mann
Interventional Cardiology Raleigh, NC Medical Doctor
NPI 1124026695 CMS profile 878955
3000 New Bern Ave, G-100, Raleigh, NC 27610
General payments
$734
Research payments
$30,900
Ownership & investment interest
$45,720
Through program year 2025, James Mann of Raleigh, NC is reported in the CMS Open Payments database as having received $734 across 2 general payments and $30,900 in research payments paid to them. They also declared ownership or investment interests valued at $45,720 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 81st percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $698 | 1 | |
| 2024 | General | $36 | 1 | |
| 2023 | Research | $3,300 | 1 | |
| 2022 | Research | $15,450 | 2 | |
| 2021 | Research | $4,200 | 1 | |
| 2020 | Research | $7,950 | 1 | |
| 2025 | Ownership | $21,120 | 1 | |
| 2024 | Ownership | $8,640 | 1 | |
| 2023 | Ownership | $4,920 | 1 | |
| 2022 | Ownership | $3,480 | 1 | |
| 2021 | Ownership | $3,480 | 1 | |
| 2020 | Ownership | $4,080 | 1 |
Beside peers
- James Mann
- Interventional Cardiology median
- Middle half of Interventional Cardiology
- National median
In program year 2025, general payments to James Mann were reported at $698. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.
Show as a table
| Year | James Mann | Interventional Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $1,097 | $329–$3,048 | $163 |
| 2020 | $0 | $473 | $161–$1,480 | $114 |
| 2021 | $0 | $677 | $233–$1,827 | $132 |
| 2022 | $0 | $978 | $333–$2,724 | $149 |
| 2023 | $0 | $1,136 | $382–$2,986 | $160 |
| 2024 | $36 | $1,181 | $395–$3,326 | $164 |
| 2025 | $698 | $1,092 | $366–$3,019 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Cardiology in North Carolina
George Adams
Interventional Cardiology · Garner, NC
Paul Mahoney
Interventional Cardiology · Greenville, NC
Ravish Sachar
Interventional Cardiology · Raleigh, NC
Patrick Simpson
Interventional Cardiology · Pinehurst, NC
Ronald Uszenski
Interventional Cardiology · Mooresville, NC
Oluseun Alli
Interventional Cardiology · Charlotte, NC
Related records
Interventional Cardiology in North Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in North Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.